388 related articles for article (PubMed ID: 29886321)
1. Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.
Ţînţaş ML; Gembus V; Alix F; Barré A; Coadou G; Truong L; Sebban M; Papamicaël C; Oulyadi H; Levacher V
Eur J Med Chem; 2018 Jul; 155():171-182. PubMed ID: 29886321
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
3. Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine "bio-oxidizable" prodrugs: Synthesis, biological evaluation and structure-activity relationship.
Azzouz R; Peauger L; Gembus V; Ţînţaş ML; Sopková-de Oliveira Santos J; Papamicaël C; Levacher V
Eur J Med Chem; 2018 Feb; 145():165-190. PubMed ID: 29324339
[TBL] [Abstract][Full Text] [Related]
4. New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation.
Pandolfi F; De Vita D; Bortolami M; Coluccia A; Di Santo R; Costi R; Andrisano V; Alabiso F; Bergamini C; Fato R; Bartolini M; Scipione L
Eur J Med Chem; 2017 Dec; 141():197-210. PubMed ID: 29031067
[TBL] [Abstract][Full Text] [Related]
5. Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy.
Bohn P; Le Fur N; Hagues G; Costentin J; Torquet N; Papamicaël C; Marsais F; Levacher V
Org Biomol Chem; 2009 Jun; 7(12):2612-8. PubMed ID: 19503937
[TBL] [Abstract][Full Text] [Related]
6. Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors.
Ahmad S; Iftikhar F; Ullah F; Sadiq A; Rashid U
Bioorg Chem; 2016 Dec; 69():91-101. PubMed ID: 27750058
[TBL] [Abstract][Full Text] [Related]
7. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.
Jiang N; Ding J; Liu J; Sun X; Zhang Z; Mo Z; Li X; Yin H; Tang W; Xie SS
Bioorg Chem; 2019 Aug; 89():103027. PubMed ID: 31176237
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase.
Peng DY; Sun Q; Zhu XL; Lin HY; Chen Q; Yu NX; Yang WC; Yang GF
Bioorg Med Chem; 2012 Nov; 20(22):6739-50. PubMed ID: 23041347
[TBL] [Abstract][Full Text] [Related]
9. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
Singh A; Sharma S; Arora S; Attri S; Kaur P; Kaur Gulati H; Bhagat K; Kumar N; Singh H; Vir Singh J; Mohinder Singh Bedi P
Bioorg Med Chem Lett; 2020 Oct; 30(20):127477. PubMed ID: 32781220
[TBL] [Abstract][Full Text] [Related]
10. New N,N-dimethylcarbamate inhibitors of acetylcholinesterase: design synthesis and biological evaluation.
De Vita D; Pandolfi F; Ornano L; Feroci M; Chiarotto I; Sileno I; Pepi F; Costi R; Di Santo R; Scipione L
J Enzyme Inhib Med Chem; 2016; 31(sup4):106-113. PubMed ID: 27594053
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
[TBL] [Abstract][Full Text] [Related]
12. Dihydroquinoline Carbamate Derivatives as "Bio-oxidizable" Prodrugs for Brain Delivery of Acetylcholinesterase Inhibitors: [¹¹C] Radiosynthesis and Biological Evaluation.
Bohn P; Gourand F; Papamicaël C; Ibazizène M; Dhilly M; Gembus V; Alix F; Ţînţaş ML; Marsais F; Barré L; Levacher V
ACS Chem Neurosci; 2015 May; 6(5):737-44. PubMed ID: 25695305
[TBL] [Abstract][Full Text] [Related]
13. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors.
Ozten O; Zengin Kurt B; Sonmez F; Dogan B; Durdagi S
Bioorg Chem; 2021 Oct; 115():105225. PubMed ID: 34364052
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
Liu S; Shang R; Shi L; Wan DC; Lin H
Eur J Med Chem; 2014 Jun; 81():237-44. PubMed ID: 24844448
[TBL] [Abstract][Full Text] [Related]
19. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
[TBL] [Abstract][Full Text] [Related]
20. Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation.
Peauger L; Azzouz R; Gembus V; Ţînţaş ML; Sopková-de Oliveira Santos J; Bohn P; Papamicaël C; Levacher V
J Med Chem; 2017 Jul; 60(13):5909-5926. PubMed ID: 28613859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
